"The thing with Lee Hood you have to realize is that he almost always is right in what he predicts," says Carl Weissman, president and CEO of Accelerator Corp., a firm whose mission is to nurture promising biotech start-ups. "But will it be three years? 15 years?" Venture capitalists, he says, like to get their return on an investment within three to 10 years.